TheEdgeResearch
Home / Stocks / GMED

Globus Medical, Inc. (GMED)

NYSE Healthcare Medical - Devices
$66.89 ▼ -2.49%
Market Cap
$8.86B
Sector
Healthcare
Industry
Medical - Devices
Beta
0.96
52-Wk Range
66.63-101.4
CEO
Keith W. Pfeil
Country
US
Currency
USD

Globus Medical, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Audubon, PA, US. The stock last traded at $66.89, down 2.49% on the session, giving a market capitalisation of $8.86B. On trailing twelve-month figures it carries a trailing P/E of 16.16, a net margin of 17.8%. Its beta of 0.96 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
16.16
Price / Sales
2.82
Price / Book
1.87
EV / EBITDA
8.66
Gross margin
70.1%
Operating margin
22.1%
Net margin
17.8%
Return on equity
—
Debt / equity
0.02
Current ratio
4.30
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
New York Stock Exchange
Employees
6,000
IPO date
2012-08-03
Headquarters
Audubon, PA, US
About Globus Medical, Inc.

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.

Comparable companies

Globus Medical, Inc. is most often compared with the following Healthcare names:

ATECBVSKIDSOFIXSIBNSNNSYKXTNTZBH
More research on GMED
GMED technical analysis GMED TheEdge Score Compare against peers
Open full interactive analysis & DCF →